It has expanded its offerings to include weight loss, focusing on prescription medications, including its own compounded semaglutide ... But some recent Hims and Hers reviews complain about ...

Its compounded semaglutide product was never the be-all and end-all for Hims & Hers ... This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before ...

The company says its semaglutide injections are fulfilled and shipped from Hims & Hers' affiliated pharmacies ... legal and regulatory (MLR) reviews. In a new pharmaphorum podcast, web editor ...

Hims saw massive revenue growth in 2024 as it sold compounded versions of Novo Nordisk’s semaglutide. This is the clinical name for Novo’s Wegovy and Ozempic. The FDA allowed this because ...

Shares of the health and wellness platform operator skyrocketed more than 670% between Jan. 1, 2024, and Feb. 19, 2025. However, this sizzling momentum came to a screeching halt in recent weeks. Hims ...

Telehealth firm Hims & Hers Health said on Tuesday it plans to sell Eli Lilly's weight-loss drug, as it widens its offerings ...

Much of the excitement over Hims & Hers has been connected to the company's sales of compounded versions of GLP-1 inhibitor semaglutide. Novo Nordisk markets semaglutide as a treatment for type 2 ...